May 2015 Archive
5431.
JSX Looks Like an Abomination but It's Good for You (medium.com)
5432.
Show HN: StrudelPy – Easy email library for Python (github.com)
5433.
How to control the zoom level with automatic face detection based image cropping (cloudinary.com)
5434.
I Bleed Aqua (lowercasecapital.com)
5435.
Ask HN: Managing an e-commerce business outside the U.S? ()
5436.
Godot 1.1 Out (godotengine.org)
5437.
The Inside Story of How the iPhone Crippled BlackBerry (wsj.com)
5438.
Why It Pays to Be a Jerk (theatlantic.com)
5439.
Show HN: Useful Mac OS X commands for your .bash_profile (github.com)
5440.
Mining Bitcoin by hand (righto.com)
5441.
The Unofficial Hacker News FAQ (2011) (jacquesmattheij.com)
5442.
China's CO2 emissions have been plummeting lately. What's going on? (vox.com)
5443.
How to get an mba from Eminem (jamesaltucher.com)
5444.
Ubuntu Core for IoT (ubuntu.com)
5445.
Adblock Plus releases standalone browser for Android (bestvpn.com)
5446.
Login and Pay with Amazon releases new SDKs, code samples, and docs (aws.amazon.com)
5447.
The iPhone bug that lets anyone crash your phone with a text message (theguardian.com)
5448.
Algorithms – hot in the art world (wsj.com)
5449.
Ad blocking software has figured out native content (qz.com)
5450.
Go ahead and break this robot’s legs. It'll figure out how to chase you without (washingtonpost.com)
5451.
OpenSeadragon JavaScript zooming library turns 2.0, adds multi-image support (blog.iangilman.com)
5452.
Automated Algorithmic Trading for Only $1 per Trade (quantconnect.com)
5453.
Emoji is dragging us back to the dark ages – and all we can do is smile (theguardian.com)
5454.
American Snipper: New Poems from John Ashbery (newyorker.com)
5455.
Show HN: Ruby on Rails Slack chat community (rubyonrails.typeform.com)
5456.
The Soylents of the Lambs (glog.glennf.com)
5457.
Musk level ideas (musklevel.com)
5458.
Google launches photo service (medium.com)
5459.
Reactive Animation with SVG, ClojureScript and Om (nvbn.github.io)
5460.
Duke Concealed Info on Potti's Fraudulent Trials from Patients for Over 2 Years (cancerletter.com)